PrLH, prolactin-releasing hormone
To view or add a comment, sign in Novo Nordisk, the maker of Ozempic, has been reigning the global weight-loss market for quite some time
Longevity Pathways To affect longevity, we must understand its pathways pathways Insulin/IGF-1 Signaling Metformin enhances insulin sensitivity and reduces IGF-1 activity, preventing overactive growth signaling that leads to abnormal cell proliferation
While branded versions of this dual-hormone therapy are currently limited to injectables, the availability of compounded oral formulations through specialized telehealth platforms has opened the door for many who previously felt excluded from these treatments
How GLP-1 Mechanisms Might Affect Brain Chemistry GLP-1 receptors exist not only in the pancreas and gastrointestinal system but also in the brain, particularly in regions governing appetite, reward processing, and mood regulation
These are general tools for mixed media as well and can be seen in this video as well